| 1 |
35282339 | Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation. | 2022 |
1 |
| 2 |
31577671 | Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function. | 2020 May |
1 |
| 3 |
27915965 | Systematic Review on Role of Mammalian Target of Rapamycin Inhibitors as an Alternative to Calcineurin Inhibitors in Renal Transplant: Challenges and Window to Excel. | 2017 Jun |
1 |
| 4 |
27795990 | Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study. | 2016 Sep |
1 |
| 5 |
25404086 | Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant. | 2015 Mar |
1 |
| 6 |
25582442 | Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients. | 2015 Feb |
1 |
| 7 |
26039212 | Haploidentical HSCT: a 15-year experience at San Raffaele. | 2015 Jun |
1 |
| 8 |
26677273 | Sirolimus as Long-term Graft-versus-host-disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplant Recipients for Non-malignant Disorders is Associated with High Incidence of Acneiform Lesions. | 2015 Nov-Dec |
1 |
| 9 |
25120315 | Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency. | 2014 Aug |
2 |
| 10 |
23223314 | Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype. | 2013 Feb |
1 |
| 11 |
23726640 | Calcineurin inhibitor conversion to rapamycin can improve graft function in living donor kidney transplantation with older donors. | 2013 May |
1 |
| 12 |
23775875 | Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. | 2013 Jul |
2 |
| 13 |
23813776 | Sirolimus as a calcineurin inhibitor- and renal-sparing agent: all good things come to those who wait versus spare the nephron, spoil the patient. | 2013 Aug |
1 |
| 14 |
24146762 | Deferred pre-emptive switch from calcineurin inhibitor to sirolimus leads to improvement in GFR and expansion of T regulatory cell population: a randomized, controlled trial. | 2013 |
1 |
| 15 |
21631587 | Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus. | 2012 Aug |
1 |
| 16 |
22320241 | Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation. | 2012 Apr |
1 |
| 17 |
22357174 | Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. | 2012 May 27 |
1 |
| 18 |
22432756 | Sirolimus conversion in liver transplant recipients with calcineurin inhibitor-induced complications: efficacy and safety. | 2012 Apr |
1 |
| 19 |
23195006 | High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. | 2012 Dec |
1 |
| 20 |
21338459 | Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation. | 2011 Jun |
1 |
| 21 |
21792049 | Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. | 2011 Aug 15 |
1 |
| 22 |
21836511 | De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results. | 2011 Oct |
1 |
| 23 |
20061930 | Omega-3 polyunsaturated fatty acids affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen. | 2010 Jan 15 |
1 |
| 24 |
20155737 | Simulation of sirolimus exposures and population variability immediately post renal transplantation: importance of the patient's CYP3A5 genotype in tailoring treatment. | 2010 Mar |
1 |
| 25 |
20232105 | Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience. | 2010 Jun |
1 |
| 26 |
20430208 | Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience. | 2010 Apr |
1 |
| 27 |
20815021 | Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis. | 2010 Oct |
1 |
| 28 |
20832541 | Sirolimus-induced isometric tubular vacuolization: a new sirolimus histopathologic manifestation. | 2010 Sep |
1 |
| 29 |
19187614 | Rapamycin instead of mycophenolate mofetil or azathioprine in treatment of post-renal transplantation urothelial carcinoma. | 2009 Jan 5 |
1 |
| 30 |
19208105 | Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients. | 2009 Jun-Jul |
1 |
| 31 |
19295318 | Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. | 2009 Mar 15 |
1 |
| 32 |
19376410 | Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence. | 2009 Apr |
1 |
| 33 |
19542890 | Renal-sparing strategies in cardiac transplantation. | 2009 Oct |
1 |
| 34 |
19923086 | [Conversion to rapamycin in liver transpant recipients with renal insufficiency]. | 2009 Nov |
2 |
| 35 |
18005087 | Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria. | 2008 Feb |
1 |
| 36 |
18217899 | Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. | 2008 Jan-Feb |
1 |
| 37 |
18562571 | Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. | 2008 Sep |
7 |
| 38 |
18657156 | Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. | 2008 Sep-Oct |
1 |
| 39 |
18793727 | Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results. | 2008 Nov |
1 |
| 40 |
18930138 | Minimization of immunosuppression: transplant immunology. | 2008 Nov |
1 |
| 41 |
19100499 | Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report. | 2008 Dec |
1 |
| 42 |
17284993 | Renal protective strategies in heart transplant patients. | 2007 Mar |
1 |
| 43 |
17401488 | Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients. | 2007 Apr |
1 |
| 44 |
17616271 | Immunosuppressive strategies to improve outcomes of kidney transplantation. | 2007 Jul |
1 |
| 45 |
17690032 | Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation. | 2007 Aug |
1 |
| 46 |
17919619 | Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction. | 2007 Oct |
1 |
| 47 |
16421477 | Thrombotic microangiopathy after lung transplantation. | 2006 Jan 15 |
1 |
| 48 |
16534470 | Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up. | 2006 Mar 15 |
1 |
| 49 |
16678029 | Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients. | 2006 May |
2 |
| 50 |
16740435 | Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients. | 2006 Jul |
1 |